?Evaluation of specific antibody titre against Pneumococcus in patients with Ataxia-telangiectasia and IgA deficiency

Phase 3

Recruiting

• Conditions: D80.2; Condition 1: Ataxia-telangiectasia. Condition 2: IgA deficiency.; Cerebellar ataxia with defective DNA repair; Selective deficiency of immunoglobulin A [IgA]; G11.3

• Registration Number: IRCT20190508043517N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 August 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Patients diagnosed with selective IgA deficiency and ataxia-telangiectasia based on defined criteria

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Ataxia-telangiectasia. Timepoint: Before intervention. Method of measurement: According to the ESID diagnostic criteria.;IgA deficiency. Timepoint: Before intervention. Method of measurement: According to the ESID diagnostic criteria.;Sex. Timepoint: Before intervention. Method of measurement: Questionnaire.;Age. Timepoint: Before intervention. Method of measurement: Questionnaire.

Secondary Outcome Measures

Name	Time	Method
Determination of the pneumococcus specific antibodies level. Timepoint: Before and after intervention. Method of measurement: ELISA.